首页> 美国卫生研究院文献>Contrast Media Molecular Imaging >Uptake of 18F-FET and 18F-FCH in Human Glioblastoma T98G Cell Line after Irradiation with Photons or Carbon Ions
【2h】

Uptake of 18F-FET and 18F-FCH in Human Glioblastoma T98G Cell Line after Irradiation with Photons or Carbon Ions

机译:用光子或碳离子辐照后人胶质母细胞瘤T98G细胞系吸收18F-FET和18F-FCH

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The differential diagnosis between recurrence of gliomas or brain metastases and this phenomenon is important in order to choose the best therapy and predict the prognosis but is still a big problem for physicians. The new emerging MRI, CT, and PET diagnostic modalities still lack sufficient accuracy. Radiolabeled choline and amino acids have been reported to show great tumor specificity. We studied the uptake kinetics of [18F]fluoromethyl-choline (FCH) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) by the T98G human glioblastoma cells from 20 to 120 min after irradiation either with photons at 2-10-20 Gy or with carbon ions at 2 Gy (at the National Centre for Oncological Hadrontherapy (CNAO), Pavia, Italy). We also evaluated the cell death and morphology changes induced by radiation treatment. Both FET and FCH are able to trace tumor behavior in terms of higher uptake for increased doses of radiation treatment, due to the upregulation of cells attempts to repair nonlethal damage. Our data suggest that both FCH and FET could be useful to analyze the metabolic pathways of glioblastoma cells before and after radiotherapy. Physicians will have to consider the different kinetics pathways of uptake concerning the two radiopharmaceuticals.
机译:胶质瘤复发或脑转移瘤与这种现象之间的鉴别诊断对于选择最佳治疗方案和预测预后很重要,但对于医生来说仍然是一个大问题。新兴的MRI,CT和PET诊断方法仍然缺乏足够的准确性。据报道,放射性标记的胆碱和氨基酸具有很大的肿瘤特异性。我们研究了[ 18 F]氟甲基胆碱(FCH)和O-(2-[ 18 F]氟乙基)-L-酪氨酸(FET)的吸收动力学用2-10-20 Gy的光子或2 Gy的碳离子照射后20至120 min的T98G人胶质母细胞瘤细胞(位于意大利帕维亚的国家肿瘤强子疗法中心(CNAO))。我们还评估了放射治疗引起的细胞死亡和形态变化。由于细胞试图修复非致死性损伤的细胞上调,因此FET和FCH都能够以更高的摄取量跟踪肿瘤行为,从而提高放射治疗剂量。我们的数据表明,FCH和FET均可用于分析放疗前后胶质母细胞瘤细胞的代谢途径。医师将不得不考虑有关两种放射性药物的不同吸收动力学途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号